Cocrystal Pharma Inc (COCP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows weak financial performance, no significant positive catalysts, and lacks clear technical or trading signals to suggest an immediate buying opportunity. It is better to hold off on investing in this stock for now.
The MACD is negatively expanding below 0, indicating bearish momentum. RSI is neutral at 41.415, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 1.021), but there is no strong indication of a reversal.
NULL identified. There is no recent news or significant trading activity from insiders or hedge funds.
The stock has shown a consistent decline in price (-4.63% in regular market and -2.78% in pre-market). Financial performance is weak, with a significant drop in net income (-58.51% YoY) and EPS (-61.22% YoY).
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$2,049,000 (-58.51% YoY), and EPS declined to -0.19 (-61.22% YoY). Gross margin remains at 0 with no improvement.
No recent analyst rating or price target changes available.